Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Shunt Admittances01:26

Shunt Admittances

Shunt admittances play a crucial role in the analysis of transmission lines, particularly for three-phase systems with neutral conductors. When a uniformly charged conductor is positioned above the Earth, it induces an equal but opposite charge on its surface. This interaction creates electric field lines between the conductor and the Earth.
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Where are effective contacts located for motor cortical stimulation? A large retrospective series.

Brain stimulation·2026
Same author

Pineal cyst surgery beyond morphology: a critical evaluation of a consecutive surgical series.

Acta neurochirurgica·2026
Same author

Abrupt Reoccurrence of Acquired Postencephalitic Hemidystonia After Unexpected Discontinuation of Thalamic DBS: An Embarrassing Situation.

Movement disorders clinical practice·2026
Same author

Polysomnographic characteristics in patients with idiopathic dystonia.

Clinical parkinsonism & related disorders·2026
Same author

Long-term efficiency of pallidal DBS and the role of Levodopa treatment in DYT-GNAL and 18p deletion syndrome associated dystonia: an observational study and review of literature.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Related Experiment Video

Updated: Jun 16, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

The adjustable proGAV shunt: a prospective safety and reliability multicenter study.

Christian Sprung1, Hans-Georg Schlosser, Johannes Lemcke

  • 1Department of Neurosurgery, Universitätsmedizin Berlin-Charité, Berlin, Germany. christian.sprung@charite.de

Neurosurgery
|February 23, 2010
PubMed
Summary

The proGAV shunt system demonstrated reliability in a multicenter study. This gravitation-assisted adjustable device proved safe for managing hydrocephalus across various patient groups.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 16, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Neurosurgery
  • Medical Device Technology
  • Hydrocephalus Management

Background:

  • Hydrocephalus requires reliable cerebrospinal fluid (CSF) shunting systems.
  • Adjustable pressure valves are crucial for optimizing CSF diversion.
  • The proGAV shunt system offers gravitation-assisted pressure regulation.

Purpose of the Study:

  • To assess the reliability and safety of the proGAV shunt system.
  • To evaluate the performance of an adjustable, gravitation-assisted shunt in a multicenter setting.
  • To determine the rate of complications and necessary adjustments for the proGAV system.

Main Methods:

  • Prospective, multicenter observational study in 10 German hospitals.
  • 165 patients with diverse hydrocephalus types were enrolled.
  • Follow-up at 3, 6, and 12 months post-implantation.

Main Results:

  • 130 of 144 assessable patients completed 12-month follow-up.
  • 14 patients required device explantation, primarily due to infection.
  • 102 valve readjustments were performed in 65 patients (underdrainage/overdrainage); no unintended readjustments occurred.

Conclusions:

  • The proGAV shunt system is a safe and reliable device for hydrocephalus treatment.
  • The adjustable valve mechanism allows for effective pressure management.
  • The study supports the clinical utility of the proGAV system in managing CSF flow.